Overview
- Grifols laid the foundation stone on Wednesday, June 3, 2026, and has begun construction of the 80,000 m² complex adjacent to its Parets del Vallès site.
- The company said the initial €160 million phase will add about 3 million liters of plasma‑fractionation capacity in Europe and is planned to be operational around 2030.
- Grifols projects the campus will create roughly 400 direct jobs, join existing facilities to form a 25‑hectare hub with about 3,700 employees, and include a fractionation plant, logistics, an analytical lab and warehouses.
- The firm describes the site as a 'smart factory' that it aims to power with 100% renewable electricity, study a biogas plant to meet up to 30% of gas needs, and cut energy use, emissions and water use by company targets.
- National and regional leaders attended the ceremony and the Generalitat has labeled the project strategic, with officials saying the investment is designed to strengthen Europe’s supply security for plasma‑derived therapies; the timetable and savings remain company projections.